Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH
Maha Fitra ND
Program Studi Spesialis-1 Jantung dan Pembuluh Darah Fakultas Kedokteran Universitas Syiah Kuala, Indonesia
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
EMPAGLIFLOZIN: TERAPI BARU UNTUK PASIEN GAGAL JANTUNG DENGAN KOMORBID DIABETES MELLITUS TIPE 2 (DMT2) Maha Fitra ND
ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH Vol. 3 No. 4 (2023): OKTOBER
Publisher : CV. ADIBA ADISHA AMIRA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Type 2 diabetes mellitus (DMT2) and heart failure have a strong relationship and one clinical outcome affects the other. Recent studies have succeeded in proving the benefits of empagliflozin, an SGLT2 inhibitor class drug (second-line drug for T2DM), on the cardiovascular system. In addition to the diuretic role, the cellular mechanism of empagliflozin that is known to play a role in animals is myocardial anti-fibrosis effect.
Co-Authors